Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NCF1 | P14598 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4311811 | 1.00 | TDP1 (0.38) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL139241 | 1.00 | TDP1 (0.38) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL10179314 | 0.97 | TDP1 (0.37) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL5675656 | 0.97 | TDP1 (0.37) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL17787332 | 0.97 | TDP1 (0.35) | TDP1KDM4EHTTCHKALMNA | |
| Hydrochloric Acid SCHEMBL3998282 | 0.94 | TDP1 (0.35) | TDP1KDM4EHTTCHKALMNA | |
| Hydrochloric Acid SCHEMBL3998279 | 0.94 | HTT (0.39) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL4318497 | 0.89 | CHKA (0.35) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL29875104 | 0.87 | KDM4E (0.32) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL29874801 | 0.87 | KDM4E (0.32) | TDP1KDM4EHTTCHKALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190188-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2011-08-04 | — | — | US | disclosed |
| US-20110143925-A1 | CATALYSTS AND METHODS FOR CATALYTIC OXIDATION | BUSCH DARYLE HADLEY | 2011-06-16 | — | — | US | disclosed |
| US-20110077187-A1 | BLEACH COMPOSITIONS | THE PROCTOR & GAMBLE COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
| US-20100298197-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2010-11-25 | — | — | US | disclosed |
| US-20100210451-A1 | CATALYSTS AND METHODS FOR CATALYTIC OXIDATION | BUSCH DARYLE HADLEY | 2010-08-19 | — | — | US | disclosed |
| US-20100190678-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-29 | — | — | US | disclosed |
| US-20100075888-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100041545-A1 | CATALYSTS AND METHODS FOR CATALYTIC OXIDATION | BUSCH DARYLE HADLEY | 2010-02-18 | — | — | US | disclosed |
| US-20080167212-A1 | Bleach compositions | BUSCH DARYLE HADLEY | 2008-07-10 | — | — | US | disclosed |
| US-20080125344-A1 | Bleach compositions | BUSCH DARYLE HADLEY | 2008-05-29 | — | — | US | disclosed |
| US-20080125343-A1 | Oxygen bleaching agent, and as transition-metal bleach catalyst a complex of a transition metal and a macropolycyclic rigid ligand; enhanced cleaning and bleaching in dishwasher or laundry detergents; e.g. 5,12-dimethyl-1,5,8,12-tetraazabicyclo[6.6.2]hexadecane manganese dichloride for example | THE PROCTER & GAMBLE COMPANY | 2008-05-29 | — | — | US | disclosed |
| US-20070093379-A1 | Catalysts and methods for catalytic oxidation | BUSCH DARYLE H | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093379-A1 | Catalysts and methods for catalytic oxidation | DUOX1, DUOX2, LPO | TDP1 3098/4885KDM4E 1605/4885HTT 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.